Published in Adv Exp Med Biol on January 01, 2012
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients | NCT04531579
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients | NCT04531592
Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model. Surgery (2014) 1.00
Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study. J Surg Res (2013) 0.89
Valproic acid attenuates lipopolysaccharide-induced acute lung injury in mice. Inflammation (2013) 0.87
Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model. PLoS One (2013) 0.81
Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model. J Surg Res (2015) 0.81
The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals. J Cachexia Sarcopenia Muscle (2013) 0.80
Development of a novel neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells. Surgery (2014) 0.79
Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock. J Trauma Acute Care Surg (2015) 0.78
Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer's Mice and in Human Patients. Curr Alzheimer Res (2015) 0.77
Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment. World J Biol Chem (2014) 0.75
HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS One (2016) 0.75
Trauma care: Finding a better way. PLoS Med (2017) 0.75
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 17.36
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell (1998) 13.98
Tissue destruction by neutrophils. N Engl J Med (1989) 13.81
Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J (2003) 11.27
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol (2007) 10.23
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol (2004) 6.88
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature (2001) 6.76
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell (1999) 6.59
Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 6.10
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A (2003) 5.56
TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science (2003) 5.25
Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol (2000) 5.24
Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res (2007) 4.91
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J (2002) 4.91
Histone deacetylase inhibitors in cancer therapy. J Clin Oncol (2009) 4.58
The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol (2001) 4.55
Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg (1992) 4.50
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2003) 4.44
p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol (2001) 4.38
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol (1997) 3.86
Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev (2003) 3.83
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci (2003) 3.67
The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J (1999) 3.58
Thioredoxin and related molecules--from biology to health and disease. Antioxid Redox Signal (2007) 3.50
Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem (2002) 3.48
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci U S A (2005) 3.20
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest (2007) 3.11
Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol (2000) 3.05
The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res (2000) 2.99
Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95
Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res (2005) 2.92
Transcriptional abnormalities in Huntington disease. Trends Genet (2003) 2.91
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol (2004) 2.90
Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J (1998) 2.84
The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol (2000) 2.69
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A (2002) 2.69
Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A (2001) 2.56
Heat shock proteins and immune system. J Leukoc Biol (2009) 2.54
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol (2000) 2.43
Post-injury multiple organ failure: the role of the gut. Shock (2001) 2.31
PTENless means more. Dev Biol (2004) 2.31
Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol (2005) 2.29
The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology (2000) 2.27
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A (2003) 2.21
Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther (2003) 2.15
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem (1999) 2.15
Transcriptional dysregulation in Huntington's disease. Trends Neurosci (2000) 2.15
hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ (2004) 2.13
The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med (2006) 2.11
New insights into PTEN. J Cell Sci (2007) 2.04
Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs (2005) 2.03
HDAC expression and clinical prognosis in human malignancies. Cancer Lett (2008) 1.99
Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin (2005) 1.95
Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci (2006) 1.92
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem (2005) 1.91
A profile of combat injury. J Trauma (2003) 1.90
Human endotoxemia as a model of systemic inflammation. Curr Med Chem (2008) 1.89
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.89
Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med (2010) 1.85
The physiology of leukocyte recruitment: an in vivo perspective. J Immunol (2008) 1.84
Histone deacetylase as a therapeutic target. Trends Endocrinol Metab (2001) 1.83
HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ (2006) 1.82
Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta (2002) 1.81
Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today (2005) 1.80
Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol (2002) 1.78
Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem (2005) 1.78
Hemorrhagic shock induces bacterial translocation from the gut. J Trauma (1988) 1.77
Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J (2008) 1.76
Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol Cell Biol (1999) 1.75
Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci U S A (2001) 1.74
Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol (2003) 1.71
Neutrophil adhesion and activation under flow. Microcirculation (2009) 1.67
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol (2006) 1.67
Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol (1998) 1.62
Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care (2001) 1.60
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci (2004) 1.58
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med (2008) 1.56
Hemorrhagic shock. Curr Probl Surg (1995) 1.53
The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem (2001) 1.53
PCAF modulates PTEN activity. J Biol Chem (2006) 1.52
The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J Biol Chem (2002) 1.52
Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem (2006) 1.50
Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis. Crit Care Med (2006) 1.48
Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2005) 1.46
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res (2007) 1.44
Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma (1995) 1.37
Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg (2001) 1.37
Physiological functions of Pten in mouse tissues. Cell Struct Funct (2003) 1.36
Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol (2002) 1.35
Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res (1999) 1.33
Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. J Leukoc Biol (2007) 1.31
Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med (2002) 1.31
Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol (2006) 1.31
Pain-associated respiratory failure in chest trauma. Anesthesiology (2013) 3.24
Making sense of the preclinical literature on advanced hemostatic products. J Trauma (2006) 2.37
Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg (2010) 1.68
Induced hypothermia for trauma: current research and practice. J Intensive Care Med (2010) 1.66
Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg (2009) 1.61
Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages. J Surg Res (2012) 1.59
Adhesional small bowel obstruction in the absence of previous operations: management and outcomes. World J Surg (2009) 1.53
Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg (2009) 1.52
Hepatic apoptosis after hemorrhagic shock in rats can be reduced through modifications of conventional Ringer's solution. J Am Coll Surg (2005) 1.46
Successful selective nonoperative management of abdominal gunshot wounds despite low penetrating trauma volumes. Arch Surg (2011) 1.46
Profound hypothermic cardiopulmonary bypass facilitates survival without a high complication rate in a swine model of complex vascular, splenic, and colon injuries. J Am Coll Surg (2007) 1.45
Fluid resuscitation: past, present, and the future. Shock (2010) 1.44
Using micropower impulse radar technology to screen for pneumothorax: an international bi-institutional study. J Trauma Acute Care Surg (2012) 1.38
Candida infection and colonization among trauma patients. Virulence (2010) 1.34
Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock (2009) 1.28
Candida infection and colonization among non-trauma emergency surgery patients. Virulence (2010) 1.27
Acute gastric dilatation in a patient with anorexia nervosa binge/purge subtype. J Emerg Trauma Shock (2010) 1.24
Surviving lethal septic shock without fluid resuscitation in a rodent model. Surgery (2010) 1.13
Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery (2008) 1.13
Hypothermia in bleeding trauma: a friend or a foe? Scand J Trauma Resusc Emerg Med (2009) 1.11
Modulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock. J Biomed Biotechnol (2011) 1.09
Falls from height: spine, spine, spine! J Am Coll Surg (2006) 1.09
Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery (2008) 1.09
Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery (2013) 1.09
Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock. J Surg Res (2009) 1.08
Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2. J Surg Res (2010) 1.08
Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma (2008) 1.08
Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. Surgery (2011) 1.07
Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion. Resuscitation (2011) 1.07
Self-expanding hemostatic polymer for control of exsanguinating extremity bleeding. J Trauma (2009) 1.06
Routine repeat head CT for minimal head injury is unnecessary. J Trauma (2006) 1.06
Emergent cricothyroidotomies for trauma: training considerations. Am J Emerg Med (2011) 1.06
Surviving blood loss without fluid resuscitation. J Trauma (2008) 1.01
Occult pneumothorax in trauma patients: development of an objective scoring system. J Trauma (2007) 0.99
Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Surgery (2007) 0.99
Case records of the Massachusetts General Hospital. Case 9-2009. An 81-year-old man with massive rectal bleeding. N Engl J Med (2009) 0.98
Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma (2008) 0.98
Searching for the optimal resuscitation method: recommendations for the initial fluid resuscitation of combat casualties. J Trauma (2003) 0.98
Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications of conventional Ringer's solution. J Trauma (2006) 0.97
Dynamic mechanical response of brain tissue in indentation in vivo, in situ and in vitro. Acta Biomater (2011) 0.96
Presenting blood pressure in traumatic brain injury: a bimodal distribution of death. J Trauma (2011) 0.96
Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults. Shock (2012) 0.96
Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation (2010) 0.96
Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery (2006) 0.95
Long-term outcome of acellular dermal matrix when used for large traumatic open abdomen. J Trauma (2008) 0.95
Pain as an indication for rib fixation: a bi-institutional pilot study. J Trauma (2011) 0.94
Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. J Surg Res (2010) 0.94
Effects of lactated Ringer's solutions on human leukocytes. J Trauma (2002) 0.93
Blunt pancreatoduodenal injury: a multicenter study of the Research Consortium of New England Centers for Trauma (ReCONECT). Arch Surg (2009) 0.92
Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock (2006) 0.92
Anti-inflammatory properties of histone deacetylase inhibitors: a mechanistic study. J Trauma Acute Care Surg (2012) 0.92
Colovesical fistula repair: is early Foley catheter removal safe? J Surg Res (2009) 0.92
Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. J Surg Res (2009) 0.91
Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis. J Trauma Acute Care Surg (2014) 0.91
Pharmacologic resuscitation decreases circulating cytokine-induced neutrophil chemoattractant-1 levels and attenuates hemorrhage-induced acute lung injury. Surgery (2012) 0.91
Therapeutic hypothermia attenuates acute lung injury in paraquat intoxication in rats. Resuscitation (2011) 0.90
Reproducibility of an animal model simulating complex combat-related injury in a multiple-institution format. Shock (2009) 0.90
Identification of expression patterns associated with hemorrhage and resuscitation: integrated approach to data analysis. J Trauma (2006) 0.90
Creating a "Prosurvival Phenotype" Through Histone Deacetylase Inhibition: Past, Present, and Future. Shock (2015) 0.89
Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg (2013) 0.89
Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model. J Surg Res (2011) 0.89
Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study. J Surg Res (2013) 0.89
Creating a "pro-survival" phenotype through epigenetic modulation. Surgery (2012) 0.87
Host-guest composites for induced hemostasis and therapeutic healing in traumatic injuries. J Thromb Thrombolysis (2006) 0.87
Early magnetic resonance imaging is unnecessary in patients with traumatic brain injury. J Trauma (2009) 0.87
D-lactate increases pulmonary apoptosis by restricting phosphorylation of bad and eNOS in a rat model of hemorrhagic shock. J Trauma (2004) 0.87
Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury. J Trauma Acute Care Surg (2012) 0.87
Assessment of coagulopathy, endothelial injury, and inflammation after traumatic brain injury and hemorrhage in a porcine model. J Trauma Acute Care Surg (2014) 0.87
Synergistic effects of hypertonic saline and valproic acid in a lethal rat two-hit model. J Trauma Acute Care Surg (2013) 0.87
Excessively long hospital stays after trauma are not related to the severity of illness: let's aim to the right target! JAMA Surg (2013) 0.87
"Blush" on trauma computed tomography: not as bad as we think! J Trauma Acute Care Surg (2012) 0.86
Profound hypothermia decreases cardiac apoptosis through Akt survival pathway. J Am Coll Surg (2009) 0.86
Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg (2015) 0.86
Percutaneous dilatational tracheostomy: review of technique and evidence for its use. J Oral Maxillofac Surg (2011) 0.85
Abdominal insufflation for control of bleeding after severe splenic injury. J Trauma (2007) 0.85
Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model. J Trauma Acute Care Surg (2015) 0.84
Induction of profound hypothermia modulates the immune/inflammatory response in a swine model of lethal hemorrhage. Resuscitation (2005) 0.84
Testing of modified zeolite hemostatic dressings in a large animal model of lethal groin injury. J Trauma (2006) 0.84
Fresh frozen plasma resuscitation attenuates platelet dysfunction compared with normal saline in a large animal model of multisystem trauma. J Trauma Acute Care Surg (2014) 0.84
Creating a prosurvival phenotype through a histone deacetylase inhibitor in a lethal two-hit model. Shock (2014) 0.84
Sternal fracture--an analysis of the National Trauma Data Bank. J Surg Res (2013) 0.84
Development and testing of low-volume hyperoncotic, hyperosmotic spray-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma (2011) 0.83
Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg (2013) 0.83
Blunt pulmonary contusion: admission computed tomography scan predicts mechanical ventilation. J Trauma (2011) 0.82
Effect of valproic acid and injury on lesion size and endothelial glycocalyx shedding in a rodent model of isolated traumatic brain injury. J Trauma Acute Care Surg (2014) 0.82
Hypothermia in multisystem trauma. Crit Care Med (2009) 0.82
Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock. Surgery (2013) 0.82
Does improved detection of blunt vertebral artery injuries lead to improved outcomes? Analysis of the National Trauma Data Bank. World J Surg (2008) 0.82
Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg (2014) 0.82
Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery (2011) 0.81
Pharmacologic modulation of cerebral metabolic derangement and excitotoxicity in a porcine model of traumatic brain injury and hemorrhagic shock. Surgery (2013) 0.81
Energy substrate-supplemented resuscitation affects brain monocarboxylate transporter levels and gliosis in a rat model of hemorrhagic shock. J Trauma (2005) 0.81
Alterations of cullin-5 mRNA levels in the rat central nervous system following hemorrhagic shock. Neurol Res (2003) 0.81
Differential effect of resuscitation on Toll-like receptors in a model of hemorrhagic shock without a septic challenge. Resuscitation (2007) 0.80
Human polymorphonuclear cell death after exposure to resuscitation fluids in vitro: apoptosis versus necrosis. J Trauma (2003) 0.80
Hernia emergencies. Surg Clin North Am (2014) 0.80
Missed opportunities for primary repair in complicated acute diverticulitis. Surgery (2010) 0.79
Alterations in the human proteome following administration of valproic acid. J Trauma Acute Care Surg (2016) 0.79
Cytokine expression profiling in human leukocytes after exposure to hypertonic and isotonic fluids. J Trauma (2002) 0.79
cDNA profiling in leukocytes exposed to hypertonic resuscitation fluids. J Am Coll Surg (2003) 0.79